Daratumumab Based Response Adapted Therapy for Older Adults With Newly Diagnosed Multiple Myeloma
Clinical trial NCT04151667 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04151667
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-22
- Primary completion
- 2023-11-08
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.